Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis

Future guidelines should consider sildenafil for IPF and further research needs to be done on promising IPF treatments such as pamrevlumab and pentraxin as phase 3 trials are completed.